ReviewEmerging infectious diseases2026
Group A Streptococcus Disease Outbreak Associated with Large Congregate Shelter, Chicago, Illinois, USA, October 2023-January 2024.
Review in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chicago Department of Public Health identified 3 pediatric patients hospitalized with group A Streptococcus (GAS) disease during October 26-November 3, 2023, in a large congregate family migrant shelter in Chicago, Illinois, USA. One patient had invasive GAS infection; 2 had peritonsillar abscesses requiring drainage. Despite infection control measures, GAS pharyngitis cases continued through November 13. Chicago Department of Public Health coordinated clinical partners to perform rapid antigen detection testing and throat cultures for residents and staff with pharyngitis symptoms. During November 20, 2023-January 3, 2024, a total of 428 symptomatic persons were evaluated; 166 tested positive for GAS. Among persons with GAS pharyngitis, median age was 12 years (range 0-45 years); 54.2% were women and girls. Common symptoms included sore throat (87.3%) and fever (63.3%). One pediatric resident death caused by invasive GAS was confirmed postmortem. This response highlights outbreak challenges in large congregate shelters housing children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.